Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03652077
What this trial is testing

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies

Who this might be right for
Cervical CancerGastric CancerStomach Cancer+18 more
Incyte Corporation 40
Not applicableNot Yet RecruitingNCT07517211
What this trial is testing

A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study

Who this might be right for
Clinical Stage I Esophageal Adenocarcinoma AJCC v8Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage I Gastric Cancer AJCC v8+9 more
Jonsson Comprehensive Cancer Center 72
Testing effectiveness (Phase 2)Study completedNCT01077999
What this trial is testing

Chemoradiation and Panitumumab for Esophageal Cancer

Who this might be right for
Squamous Cell CarcinomaAdenocarcinomaEsophageal Cancer+1 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 78
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Testing effectiveness (Phase 2)Looking for participantsNCT05969860
What this trial is testing

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Who this might be right for
Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more
Mayo Clinic 220
Testing effectiveness (Phase 2)Active Not RecruitingNCT01512589
What this trial is testing

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

Who this might be right for
Esophageal Cancer
M.D. Anderson Cancer Center 147
Testing effectiveness (Phase 2)Study completedNCT00397904
What this trial is testing

Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center 16
Early research (Phase 1)Looking for participantsNCT06657144
What this trial is testing

CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Coherus Oncology, Inc. 154
Testing effectiveness (Phase 2)WithdrawnNCT03307941
What this trial is testing

Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionSquamous Cell Carcinoma of the Esophagus
Jules Bordet Institute
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117
What this trial is testing

Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc. 329
Not applicableLooking for participantsNCT04290806
What this trial is testing

Registry Platform Gastric/Esophageal Cancer (SAPHIR)

Who this might be right for
Esophageal Squamous Cell CarcinomaGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+1 more
iOMEDICO AG 1,900
Early research (Phase 1)Ended earlyNCT04144140
What this trial is testing

Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101

Who this might be right for
LymphomaAdvanced Solid Tumors
Eisai Inc. 24
Not applicableNo Longer AvailableNCT04681248
What this trial is testing

Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors

Who this might be right for
Esophageal NeoplasmAdenocarcinoma of the Gastroesophageal JunctionGastroEsophageal Cancer+7 more
Leap Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT01178944
What this trial is testing

Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Undifferentiated CarcinomaGastric Adenocarcinoma+14 more
Roswell Park Cancer Institute 35
Not applicableLooking for participantsNCT04221893
What this trial is testing

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

Who this might be right for
Stage IV Esophageal AdenocarcinomaStage IV Esophageal Squamous Cell CarcinomaStage IV Gastric Cancer+41 more
University of California, San Francisco 28
Early research (Phase 1)Active Not RecruitingNCT04460937
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

Who this might be right for
Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+56 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT05059444
What this trial is testing

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Who this might be right for
Bladder CarcinomaUreter CarcinomaRenal Pelvis Carcinoma+14 more
Guardant Health, Inc. 2,285
Testing effectiveness (Phase 2)Study completedNCT00045526
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionRecurrent Esophageal Cancer+3 more
National Cancer Institute (NCI) 48
Not applicableStudy completedNCT04161781
What this trial is testing

PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

Who this might be right for
Esophagogastric CancerEsophagus CancerEsophageal Cancer+4 more
Memorial Sloan Kettering Cancer Center 10
Next Page
4